| Patents for A61P 13 - Drugs for disorders of the urinary system (56,135) |
|---|
| 05/22/1998 | WO1998021237A2 Peptide compounds useful for modulating fgf receptor activity |
| 05/22/1998 | WO1998021228A1 Tissue specific expression of retinoblastoma protein |
| 05/22/1998 | WO1998021207A1 (2,3-dihydrobenzofuranyl)-thiazoles as phosphodiesterase inhibitors |
| 05/22/1998 | WO1998021183A1 Pure enantiomer basic aryl-cycloalkyl-hydroxycarboxylic acid esters, process for preparing the same and their use in medicaments |
| 05/22/1998 | CA2270873A1 Secreted proteins and polynucleotides encoding them |
| 05/22/1998 | CA2270871A1 Peptide compounds useful for modulating fgf receptor activity |
| 05/20/1998 | EP0843016A2 Staphylococcus FabD (malonylCoA:ACP transacylase) protein |
| 05/20/1998 | EP0843011A2 RsbU-1 derived from Staphylococcus |
| 05/20/1998 | EP0842923A1 Pyrrole derivatives and medicinal composition |
| 05/20/1998 | EP0842148A1 Benzenesulphonamide derivatives, preparation thereof and therapeutical uses thereof |
| 05/20/1998 | EP0841953A1 Method and apparatus for interstitial radiation of the prostate gland |
| 05/20/1998 | EP0841940A1 Isolation and/or preservation of dendritic cells for prostate cancer immunotherapy |
| 05/20/1998 | EP0841937A1 Use of betaglycan to reduce scarring |
| 05/20/1998 | EP0841935A1 Modulation of endothelial cell proliferation |
| 05/20/1998 | EP0841925A1 Endothelin receptor antagonists |
| 05/20/1998 | EP0841919A1 Inhibitors of farnesyl-protein transferase |
| 05/20/1998 | EP0741708B1 Cyanoguanidines as k-channel blockers |
| 05/20/1998 | EP0651735B1 Pharmacologically active alpha-(tertiary-aminomethyl)-phenylmethanol derivatives |
| 05/20/1998 | CN1182368A Immanomodulating compositions from bile for treatment of immune system disorders |
| 05/20/1998 | CN1182366A Use of nitric oxide donors or nitric oxide inhibitors for regulation cervical dilatation and extensiblity |
| 05/20/1998 | CN1038413C Prep. of amides for treatment |
| 05/19/1998 | US5753710 Substituted benzyloxycarbonylguanidines, a process for their preparation, their use as a medicament or diagnostic, and a medicament containing them |
| 05/19/1998 | US5753706 Methods for treating renal failure |
| 05/19/1998 | US5753648 Tricyclic benzazepine vasopressin antagonists |
| 05/19/1998 | US5753641 Method of treatment for benign prostatic hyperplasia |
| 05/14/1998 | WO1998020011A1 3-CARBOXAMIDE DERIVATIVES OF 5H-PYRROLO[2,1-c][1,4]-BENZODIAZEPINES |
| 05/14/1998 | WO1998019696A1 Hepatocyte growth factor antagonists |
| 05/14/1998 | CA2270867A1 Hepatocyte growth factor antagonists |
| 05/13/1998 | EP0840732A1 Substituted benzolactam compounds as substance p antagonists |
| 05/13/1998 | EP0840728A1 Heteroaryl diol acids as leukotriene antagonists |
| 05/13/1998 | EP0668872B1 Calcium channel blocking polypeptides from theraphosidae aphonopelma |
| 05/13/1998 | CN1181700A Mercapto and seleno derivatives as inhibitors of nitric oxide synthase |
| 05/12/1998 | US5750712 Diabetic therapy |
| 05/12/1998 | US5750693 Disubstituted acetylenes bearing heterobicyclic groups and heteroaromatic or phenyl groups having retinoid like activity |
| 05/12/1998 | US5750687 Angiotensin converting enzyme inhibitors, neutral endopeptidase inhibitors |
| 05/12/1998 | US5750557 Method and pharmaceutical formulation for treating benign prostatic hyperplasia |
| 05/12/1998 | US5750554 Compounds for treatment of anxiety, depression, antisecretory agents, hypotensive agents and treatment of eating problems |
| 05/12/1998 | US5750539 Antiasthmatics |
| 05/12/1998 | US5750521 Mercaptoacetylamide disulfide derivatives useful as inhibitors of enkephalinase and ACE |
| 05/12/1998 | US5750495 Administering tumor necrosis factor |
| 05/12/1998 | US5750387 DNA encoing leucyl TRNA synthetase from staphylococcus aureus |
| 05/12/1998 | US5750137 Drug delivery, permeability, glycerides and lactates |
| 05/07/1998 | WO1998018788A1 Piperazino derivatives as neurokinin antagonists |
| 05/07/1998 | WO1998018757A1 Synthesis of benzo[f]quinolinones |
| 05/07/1998 | WO1998018493A2 Conjugates useful in the treatment of prostate cancer |
| 05/07/1998 | WO1998018487A1 Prophylactic/remedial agent |
| 05/07/1998 | WO1998018467A1 Compositions for the treatment of renal failure, comprising l-carnosine |
| 05/07/1998 | WO1998018430A2 P2y receptor antagonists |
| 05/07/1998 | WO1998009985A3 Anti-inflammatory peptides and uses thereof |
| 05/07/1998 | CA2270433A1 Synthesis of benzo¬f|quinolinones |
| 05/07/1998 | CA2268738A1 Conjugates useful in the treatment of prostate cancer |
| 05/07/1998 | CA2241687A1 P2y receptor antagonists |
| 05/07/1998 | CA2241458A1 Compositions for the treatment of renal failure, comprising l-carnosine |
| 05/06/1998 | EP0839910A2 Spo-rel, a Staphylococcus relA/spot homologue |
| 05/06/1998 | EP0839814A2 Indolocarbazole derivatives and their use for the treatment of prostate gland disorders |
| 05/06/1998 | EP0839807A1 Synthesis of benzo(f)quinolinones |
| 05/06/1998 | EP0839145A1 Heterocyclylcarboxamide derivatives and their use as therapeutic agents |
| 05/06/1998 | EP0839144A1 Piperazine derivatives as therapeutic agents |
| 05/06/1998 | EP0839040A1 Use of cgmp-phosphodiesterase inhibitors to treat impotence |
| 05/06/1998 | EP0788364A4 Treatment of urogenital cancer with boron neutron capture therapy |
| 05/06/1998 | CN1181084A Tricyclic benzazepine vasopression antagonists |
| 05/06/1998 | CN1181075A Substituted isoxazoles for the treatment of inflammation |
| 05/06/1998 | CN1181019A Combination compositions containing benazepril or beazeprilat and valsartan |
| 05/06/1998 | CN1181016A Use of hyaluronic acid for the treatment of interstitial cystitis |
| 05/05/1998 | US5747541 Substituted benzoylguanidines, a process for their preparation, their use as medicament of diagnostic agent, and medicament comprising them |
| 05/05/1998 | US5747318 Mitogen activated c-Fos regulating kinase, FRK |
| 05/05/1998 | US5747065 Monoglyceride/lactate ester permeation enhancer for oxybutynin |
| 04/29/1998 | EP0838523A2 RsbW-1 derived from Staphylococcus |
| 04/29/1998 | EP0838221A1 Lyophilized hgf preparations |
| 04/29/1998 | EP0838213A1 Use of Krill Enzymes for the Treatment of Dental Plaque |
| 04/29/1998 | EP0837690A1 A stabilized pharmaceutical formulation comprising a growth hormone and a peptide comprising at least one basic amino acid residue and at least one acid amino acid residue |
| 04/29/1998 | EP0837681A2 Use of 19-nor-vitamin d compounds for the prevention of hyperphosphatemia in kidney disorder patients |
| 04/29/1998 | CN1180352A Aryl glycinamide derivatives, methods of producing these substances and pharmaceutical compositions containing such compounds |
| 04/29/1998 | CN1180351A Benzothiazine dioxides as endothelin antagonists |
| 04/29/1998 | CN1180311A Use of 'alpha' 1L agonists in treatment of incontinence |
| 04/29/1998 | CA2214866A1 Novel spo-rel |
| 04/28/1998 | US5744641 Sulfonyl- or sulfinylbenzoylguanidine derivatives |
| 04/28/1998 | US5744607 Basic derivatives of glutamic acid and aspartic acid as gastrin or cholecystokinin antagonists |
| 04/28/1998 | US5744488 Indole derivatives thromboxane A2 antagonists |
| 04/28/1998 | US5744474 Administering venlafaxine or duloxetine; treating stress, urge and/or nocturnal urinary incontinence |
| 04/28/1998 | US5744464 Dysmennhorea |
| 04/28/1998 | US5744451 N-substituted glutamic acid derivatives with interleukin-1 β converting enzyme inhibitory activity |
| 04/28/1998 | US5744448 Human follicle stimulating hormone receptor |
| 04/28/1998 | CA2203621C Use of hyaluronic acid for the treatment of interstitial cystitis |
| 04/23/1998 | WO1998016520A1 The preparation and use of ortho-sulfonamido heteroaryl hydroxamic acids as matrix metalloproteinase and tace inhibitors |
| 04/23/1998 | WO1998016506A1 Beta-sulfonamido hydroxamic acids as matrix metalloproteinase and tace inhibitors |
| 04/23/1998 | WO1998016503A2 The preparation and use of ortho-sulfonamido aryl hydroxamic acids as matrix metalloproteinase and tace inhibitors |
| 04/23/1998 | WO1998016225A1 Treatment of urinary incontinence and compositions for use therein |
| 04/23/1998 | WO1998009992A3 Htm4, methods of treatment and assays, agonists and antagonists |
| 04/23/1998 | CA2268897A1 The preparation and use of ortho-sulfonamido heteroaryl hydroxamic acids as matrix metalloproteinase and tace inhibitors |
| 04/23/1998 | CA2268895A1 Beta-sulfonamido hydroxamic acids as matrix metalloproteinase and tace inhibitors |
| 04/23/1998 | CA2268894A1 The preparation and use of ortho-sulfonamido aryl hydroxamic acids as matrix metalloproteinase and tace inhibitors |
| 04/22/1998 | EP0837129A1 Epimorphin antagonist and process for producing the same |
| 04/22/1998 | EP0837073A1 Human mad proteins and uses thereof |
| 04/22/1998 | EP0836621A1 Novel human g-protein coupled receptor |
| 04/22/1998 | EP0836476A1 A cosmetic antimycotic composition for skin applications and pharmaceutical composition for the treatment of tumorous cells, bladder or nerve disorders |
| 04/22/1998 | CN1179774A Arginine analogues having nitric oxide synthase inhibitor activity |
| 04/22/1998 | CN1179714A Treating urinary incontinence using (s)-oxybutynin and (s) -desethyloxybutynin |
| 04/22/1998 | CN1179418A Novel cyloalkyl derivatives as inhibitors of bone resorption and vitronectin receptor antagonists |
| 04/21/1998 | US5741815 Methods for in vivo reduction of nitric oxide levels and compositions useful therefor |